Pricing Log in Create free account

NovaBridge Biosciences (NBP) vs OnKure Therapeutics, Inc. (OKUR)

NovaBridge Biosciences and OnKure Therapeutics, Inc. are both Biotechnology companies. NovaBridge Biosciences and OnKure Therapeutics, Inc. are of similar size ($105.3M and $102.3M). Across the 10 metrics below, NovaBridge Biosciences leads on 5 and OnKure Therapeutics, Inc. on 5.

Valuation

Metric NBP OKUR Biotechnology median
P/E n/m n/m 10.60
P/S 3.79 n/m 9.40
P/B 0.37 0.88 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 2.71 0.37 0.66
EV/Sales (5.33) n/m 9.02
Earnings yield (54.06%) (99.19%) (32.88%)
Free cash flow yield (125.76%) (34.41%) (23.13%)

Profitability

Metric NBP OKUR Biotechnology median
Gross margin 31.10% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (55.18%) (51.96%)
Return on assets 0.00% (51.56%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric NBP OKUR Biotechnology median
Revenue growth (TTM) (91.84%) — 6.76%
EPS growth (last fiscal year) (77.78%) 71.20% 29.88%
Revenue growth, 5-year CAGR (40.00%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NBP OKUR Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.64 18.84 4.97
Net debt to EBITDA 2.26 0.95 1.01

Dividend

Metric NBP OKUR Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric NBP OKUR Biotechnology median
Market cap 105.34m 102.26m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack